"2"^^ . "1"^^ . "Lata, Jan" . "Sv\u011Btov\u00E1 zdravotnick\u00E1 organizace (WHO) definuje probiotika jako \u017Eiv\u00E9 mikroorganizmy, kter\u00E9, pokud jsou pod\u00E1ny v adekv\u00E1tn\u00EDm mno\u017Estv\u00ED, maj\u00ED p\u0159\u00EDzniv\u00FD vliv na zdrav\u00ED hostitele. V \u010Dl\u00E1nku jsou uvedeny z\u00E1kladn\u00ED informace t\u00FDkaj\u00EDc\u00ED se mikrofl\u00F3ry tr\u00E1vic\u00EDho traktu, faktory ji ovliv\u0148uj\u00EDc\u00ED a jej\u00ED funkce. D\u00E1le je uveden p\u0159ehled terapeutick\u00E9ho vyu\u017Eit\u00ED probiotik v gastroenterologii (pr\u016Fjmy, idiopatick\u00E9 st\u0159evn\u00ED z\u00E1n\u011Bty, dr\u00E1\u017Ediv\u00FD tra\u010Dn\u00EDk, divertikul\u00E1rn\u00ED choroba tra\u010Dn\u00EDku, l\u00E9\u010Dba infekce Helicobacter pylori, akutn\u00ED pankreatitida a prevence vzniku kolorekt\u00E1ln\u00EDho karcinomu) a hepatologii (jatern\u00ED encefalopatie, ovlivn\u011Bn\u00ED bakteri\u00E1ln\u00ED translokace a nealkoholick\u00E1 steatohepatitida)." . . "probiotika; gastroenterologie; hepatologie; st\u0159evn\u00ED mikrofl\u00F3ra; koloniza\u010Dn\u00ED rezistence; st\u0159evn\u00ED slizni\u010Dn\u00ED bari\u00E9ra"@en . . . . "St\u0159evn\u00ED mikrofl\u00F3ra, slizni\u010Dn\u00ED bari\u00E9ra a probiotika u n\u011Bkter\u00FDch intern\u00EDch chorob" . "Sv\u011Btov\u00E1 zdravotnick\u00E1 organizace (WHO) definuje probiotika jako \u017Eiv\u00E9 mikroorganizmy, kter\u00E9, pokud jsou pod\u00E1ny v adekv\u00E1tn\u00EDm mno\u017Estv\u00ED, maj\u00ED p\u0159\u00EDzniv\u00FD vliv na zdrav\u00ED hostitele. V \u010Dl\u00E1nku jsou uvedeny z\u00E1kladn\u00ED informace t\u00FDkaj\u00EDc\u00ED se mikrofl\u00F3ry tr\u00E1vic\u00EDho traktu, faktory ji ovliv\u0148uj\u00EDc\u00ED a jej\u00ED funkce. D\u00E1le je uveden p\u0159ehled terapeutick\u00E9ho vyu\u017Eit\u00ED probiotik v gastroenterologii (pr\u016Fjmy, idiopatick\u00E9 st\u0159evn\u00ED z\u00E1n\u011Bty, dr\u00E1\u017Ediv\u00FD tra\u010Dn\u00EDk, divertikul\u00E1rn\u00ED choroba tra\u010Dn\u00EDku, l\u00E9\u010Dba infekce Helicobacter pylori, akutn\u00ED pankreatitida a prevence vzniku kolorekt\u00E1ln\u00EDho karcinomu) a hepatologii (jatern\u00ED encefalopatie, ovlivn\u011Bn\u00ED bakteri\u00E1ln\u00ED translokace a nealkoholick\u00E1 steatohepatitida)."@cs . "Intestinal microflora, mucosal barrier and probiotics in some internal diseases"@en . . . . "St\u0159evn\u00ED mikrofl\u00F3ra, slizni\u010Dn\u00ED bari\u00E9ra a probiotika u n\u011Bkter\u00FDch intern\u00EDch chorob" . . "Intestinal microflora, mucosal barrier and probiotics in some internal diseases"@en . "St\u0159evn\u00ED mikrofl\u00F3ra, slizni\u010Dn\u00ED bari\u00E9ra a probiotika u n\u011Bkter\u00FDch intern\u00EDch chorob"@cs . "7"^^ . . . "17110" . "13" . "[3409AF12893B]" . . "1212-7299" . "St\u0159evn\u00ED mikrofl\u00F3ra, slizni\u010Dn\u00ED bari\u00E9ra a probiotika u n\u011Bkter\u00FDch intern\u00EDch chorob"@cs . "Jur\u00E1nkov\u00E1, Jana" . . . . "RIV/61988987:17110/11:A12013KY!RIV12-MSM-17110___" . "RIV/61988987:17110/11:A12013KY" . "The Health Organization probiotics definition is live microorganisms which when administered in adequate amounts confer a health benefit on the host. This review addresses the concept of intestinal microflora and their function and evidence regarding the possible uses of probiotics in gastroenterology (diarrhoe, idiopatic bowel diseases, Helicobacter pylori infection, acute pancreatitis a prevention of colorectal cancer) and hepatology (hepatic encephalopathy, effect on bacterial intestinal translocation and non-alcoholic steatohepatitis)."@en . . . . "V" . "-" . "2" . "232662" . "CZ - \u010Cesk\u00E1 republika" . .